hepatocellular-carcinoma

Documents about hepatocellular-carcinoma

• Celebrex and Metformin for Postoperative Hepatocellular Carcinoma#143813ClinicalTrials.gov
• Trajectory-Based Prognostic Modeling in Hepatocellular Carcinoma#283059ClinicalTrials.gov
• TheraSphere With Durvalumab and Tremelimumab for HCC#407726ClinicalTrials.gov
• Durvalumab and Tremelimumab in Resectable HCC#474758ClinicalTrials.gov
• Predictive Model for Pain After TACE#870519ClinicalTrials.gov
• Research on Effectiveness and Safety of the Treatment, Hyperthermic Intraperitoneal Chemotherapy Combined With Tislelizumab and Targeted Therapy, That is Used for High-risk Hepatocellular Carcinoma After R0 Resection#249586ClinicalTrials.gov
• Machine Learning Models for Disease-Free Survival Analysis after Liver Resection for Hepatocellular Carcinoma: A Multicentric French Collaborative Study#308231HAL (France)
• State of abdominal CT datasets: A critical review of bias, clinical relevance, and real-world applicability#443310PLOS
• Nurse-led hepatocellular carcinoma surveillance clinic provides an effective method of monitoring patients with cirrhosis#672578Research Online
• AI-Guided First-Line Immunotherapy Selection in Unresectable Hepatocellular Carcinoma#852431ClinicalTrials.gov
• PD-1/PD-L1 Inhibitors and Anti-angiogenic Therapy Combined With/Without TACE/HAIC in Patients With BCLC B/C Hepatocellular Carcinoma Beyond Up-to-7#898873ClinicalTrials.gov
• Biomarkers in Stored Tumor Samples From Younger Patients With Liver Cancer#900479ClinicalTrials.gov
• Liver Transplantation With ADV-TK Gene Therapy Improves Survival in Patients With Advanced Hepatocellular Carcinoma#901243ClinicalTrials.gov
• A Study on the Safety and Effectiveness of IBI318 Combined With Conventional TACE (cTACE) as a Perioperative Treatment for Potentially Resected Hepatocellular Carcinoma#906890ClinicalTrials.gov
• A Platform Trial for Personalized and Adaptive Therapies in Hepatocellular Carcinoma#853805ClinicalTrials.gov
• Coriolus Versicolor as Palliative Therapy Compared to Placebo in Patients With Child-Pugh C Unresectable Hepatocellular Carcinoma#852945ClinicalTrials.gov
• Endoarterial Treatment in Combination With Percutaneous Thermoablation for Medium-sized and Oligonodular Hepatocellular Carcinomas#805818ClinicalTrials.gov
• Radiotherapy in Hepatocellular Carcinomas After Hepatectomy With Narrow Margin (<1 cm) and / or Microvascular Invasion#826564ClinicalTrials.gov
• Resection for Multiple Hepatocellular Carcinomas (HCC)#902365ClinicalTrials.gov
• Supporting data for "Pt1a and tyrosine kinase inhibitor combination treatment exerts synergistic anti-hepatocellular carcinoma effect through RNA m6A methylation modification".#344096Figshare
• Trametinib Combined With Everolimus and Lenvatinib for Recurrent/Refractory Advanced Solid Tumors#807557ClinicalTrials.gov
• The Impact on Survival of Neo-adjuvant Transarterial Chemoinfusion (TAI) for Patients With Beyond Milan Criteria BCLC Stage A/B Hepatocellular Carcinoma Who Underwent Hepatectomy#813976ClinicalTrials.gov
• A Trial of SHR-8068 Combined With Adebrelimab and Apatinib in Perioperative Treatment of Resectable Hepatocellular Carcinoma#828126ClinicalTrials.gov
• Ablation of Oligometastasis Combined With Lenvatinib and PD-1 Inhibitor for Advanced Hepatocellular Carcinoma#880736ClinicalTrials.gov
• The Study of Apatinib Plus Radiotherapy vs. Apatinib in the Treatment of Hepatocellular Carcinoma With BCLC-C Stage I and Stage II Portal Vein Tumor Thrombus#887053ClinicalTrials.gov
• Liquid Biopsy in Hepatocellular Carcinoma#238121ClinicalTrials.gov
• Unilateral Stenting Versus Bilateral Stenting for Malignant Hilar Biliary Obstruction#801514ClinicalTrials.gov
• Factors Influencing the 3-Year Recurrence of Liver Carcinoma After Surgery#904736ClinicalTrials.gov
• 29-Gene Liver Cancer Subtype and Immunotherapy Effectiveness#125857ClinicalTrials.gov
• Hepatocellular carcinoma surveillance: a health economic evaluation.#148420NCBI PubMed Central
• SynOV1.1 Intratumoral Injection Study#844824ClinicalTrials.gov
• HAIC + Atezolizumab Plus Bevacizumab in Unresectable HCC#874237ClinicalTrials.gov
• Neoadjuvant Triple Therapy for Resectable HCC#899025ClinicalTrials.gov
• A Trial of Hepatic Arterial Infusion Combined With Apatinib and Camrelizumab Versus Apatinib and Camrelizumab for C-staged Hepatocellular Carcinoma in BCLC Classification#369827ClinicalTrials.gov
• The Efficacy and Safety of First-line Treatment Combined With Immunotherapy for Advanced Hepatocellular Carcinoma: a Single Center, Real-world Study#426782ClinicalTrials.gov
• Triple Recipient Strategy Using Split, Domino, and Auxiliary Techniques#800567ClinicalTrials.gov
• Trial of Atezolizumab and Bevacizumab With SRF388 or Placebo in Patients With Hepatocellular Carcinoma#800894ClinicalTrials.gov
• The Role of Long Non-coding RNAs WRAP53 and UCA-1 as Potential Biomarkers in Diagnosis of Hepatocellular Carcinoma#830823ClinicalTrials.gov
• Primary Prevention of Patients With Hepatocellular Carcinoma and Concomitant Esophageal Varices#831371ClinicalTrials.gov
• Donafenib Combine With Sintilimab and HAIC (Hepatic Artery Infusion Chemotherapy，HAIC）in the First-line Treatment of Unresectable Hepatocellular Carcinoma#844082ClinicalTrials.gov
• Preoperative Transarterial Chemoembolization for Resectable HCC With Portal Venous Invasion#848693ClinicalTrials.gov
• Allogeneic Gamma-delta T Cells Combined With Targeted Therapy and Immunotherapy in a Phase 1 Clinical Trial of Hepatocellular Carcinoma Resistant to PD-1 Monoclonal Antibody#849116ClinicalTrials.gov
• Safety and Feasibility of CIK Cell Therapy in HCC After Tumor Resection#869415ClinicalTrials.gov
• Evaluation of Stereotactic Body Radiotherapy as a Bridge Therapy for Hepatocellular Carcinoma Patients Enlisted for Liver Transplantation#886200ClinicalTrials.gov
• To Evaluate the Efficacy and Safety of (18F-FCH) Comparing With (18F-FDG) for Detecting Hepatocellular Carcinoma#886865ClinicalTrials.gov
• Adjuvant Radiotherapy of Sintilimab Versus TACE for HCC#896675ClinicalTrials.gov
• Safety, Pharmacokinetics and Preliminary Anti-Tumor Activity of Intravenous TKM-080301 in Subjects With Advanced Hepatocellular Carcinoma#885672ClinicalTrials.gov
• The Emerging Role of Metformin in the Treatment of Hepatocellular Carcinoma: Is There Any Value in Repurposing Metformin for HCC Immunotherapy?#254411IRIS
• A Phase III Clinical Trial of AK105 Injection Combined With Anlotinib Hydrochloride Capsules Versus Sorafenib in Subjects With Advanced Hepatocellular Carcinoma (HCC)#847450ClinicalTrials.gov
• Neo-adjuvant Transarterial Chemoinfusion (TAI) for Patients With Hepatocellular Carcinoma Beyond Milan/UCSF Criteria Who Underwent Liver Transplantation#860212ClinicalTrials.gov